Corcept Therapeutics appoints Daniel Swisher to board
This article was originally published in Scrip
Executive Summary
Corcept Therapeutics, a pharmaceutical company developing drugs for the treatment of severe metabolic, oncologic and psychiatric disorders, has named Daniel N Swisher Jr to its board of directors. Mr Swisher is currently CEO and a board member of Sunesis Pharmaceuticals, a clinical-stage oncology company.